Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Operating Expenses | 2,570 | 2,193 | 3,332 | 4,565 | 5,619 |
| Operating Income | -2,570 | -2,193 | -3,332 | -4,565 | -5,619 |
| Other Income | -305 | -206 | -7 | 2 | 75 |
| Pre-tax Income | -2,875 | -2,399 | -3,339 | -4,563 | -5,544 |
| Net Income Continuous | -2,875 | -2,399 | -3,339 | -4,563 | -5,544 |
| Net Income | $-2,875 | $-2,399 | $-3,339 | $-4,563 | $-5,544 |
| EPS Basic Total Ops | -19.49 | -16.49 | -23.99 | -31.48 | -38.98 |
| EPS Basic Continuous Ops | -19.81 | -16.88 | -23.50 | -32.19 | -39.15 |
| EPS Diluted Total Ops | -19.49 | -16.49 | -23.99 | -31.48 | -38.98 |
| EPS Diluted Continuous Ops | -19.81 | -16.88 | -23.50 | -32.19 | -39.15 |
| EBITDA(a) | $-2,487 | $-2,107 | $-3,249 | $-4,456 | $-5,529 |